| 1 |
34702339 | Therapeutic activity of sarpogrelate and dopamine D2 receptor agonists on cardiovascular and renal systems in rats with alloxan-induced diabetes. | 2021 Oct 26 |
2 |
| 2 |
33174181 | Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission. | 2020 Dec |
2 |
| 3 |
29944910 | Blockade of serotonin 5-HT2A receptors potentiates dopamine D2 activation-induced disruption of pup retrieval on an elevated plus maze, but has no effect on D2 blockade-induced one. | 2018 Aug |
1 |
| 4 |
25637799 | Stimulation of glutamate receptors in the ventral tegmental area is necessary for serotonin-2 receptor-induced increases in mesocortical dopamine release. | 2015 Apr 2 |
1 |
| 5 |
26508706 | 5-HT2 receptors modulate the expression of antipsychotic-induced dopamine supersensitivity. | 2015 Dec |
4 |
| 6 |
23969614 | Behavioral effects of clozapine, pimavanserin, and quetiapine in rodent models of Parkinson's disease and Parkinson's disease psychosis: evaluation of therapeutic ratios. | 2013 Oct |
1 |
| 7 |
22886755 | 5-HT(2A) receptor blockade and 5-HT(2C) receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen. | 2012 Dec |
1 |
| 8 |
21527662 | Tracheal occlusion modulates the gene expression profile of the medial thalamus in anesthetized rats. | 2011 Jul |
1 |
| 9 |
18035407 | Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons. | 2008 Aug |
1 |
| 10 |
18597077 | Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat. | 2008 Nov |
3 |
| 11 |
15999145 | Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex. | 2006 Feb |
3 |
| 12 |
15993442 | Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958. | 2005 Sep |
1 |
| 13 |
16001122 | Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats. | 2005 Oct |
1 |
| 14 |
15044557 | Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism. | 2004 Aug |
2 |
| 15 |
11850146 | 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. | 2002 Mar |
1 |
| 16 |
11238736 | 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. | 2001 Mar |
1 |
| 17 |
11430898 | DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release. | 2001 Jul 13 |
3 |
| 18 |
10646521 | Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum. | 2000 Feb |
1 |
| 19 |
10987844 | Serotonin 5-HT(2) receptor stimulation of dopamine release in the posterior but not anterior nucleus accumbens of the rat. | 2000 Oct |
1 |
| 20 |
11126398 | The 5-HT2 antagonist ritanserin blocks dopamine re-uptake in the rat frontal cortex. | 2000 Nov |
1 |
| 21 |
10461892 | Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation. | 1999 Sep |
1 |
| 22 |
10669905 | Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics. | 1999 Nov |
1 |
| 23 |
9443541 | Action of the 5-HT2A antagonist amperozide on alcohol-induced poikilothermia in rats. | 1998 Jan |
1 |
| 24 |
9689464 | Crucial role of the 5-HT2C receptor, but not of the 5-HT2A receptor, in the down regulation of stimulated dopamine release produced by pressure exposure in freely moving rats. | 1998 Jun 15 |
1 |
| 25 |
9194148 | Ritanserin administration potentiates amphetamine-stimulated dopamine release in the rat prefrontal cortex. | 1997 May |
1 |
| 26 |
8840347 | Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats. | 1996 Aug |
1 |
| 27 |
7636736 | Ritanserin, a 5-HT2A/2C antagonist, reverses direct dopamine agonist-induced inhibition of midbrain dopamine neurons. | 1995 Aug |
2 |
| 28 |
7737334 | The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat. | 1995 Feb 6 |
2 |
| 29 |
7791076 | Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra. | 1995 Jun |
2 |
| 30 |
2568733 | The 5-HT2 antagonist ritanserin blocks the effect of pre-frontal cortex inactivation on rat A10 dopamine neurons in vivo. | 1989 Jul |
1 |